文章摘要
参连合用对代谢综合征患者“肠道菌群-免疫反应”的影响
Effect of Shenlian combination on “intestinal flora-immune response” in patients with metabolic syndrome
  
DOI:10.3969/j.issn.1007-8134.2021.03.012
中文关键词: 代谢综合征  参连合用  肠道菌群  免疫反应  免疫炎性因子  降糖  降脂  综合治疗
英文关键词: metabolic syndrome  Shenlian combination  intestinal flora  immune response  immune inflammatory factor  hypoglycemic  lipid lowering  comprehensive treatment
基金项目:同仁医院一般学科建设项目(tr2020xk27);上海市卫生和计划生育委员会中医药科研课题(2018LQ015)
作者单位
蔡之幸 上海交通大学医学院附属同仁医院中医科 
陈 越 上海交通大学医学院附属同仁医院中医科 
陈莉莉 上海交通大学医学院附属同仁医院中医科 
李 丽 上海交通大学医学院附属同仁医院中医科 
摘要点击次数: 566
全文下载次数: 399
中文摘要:
      目的 观察参连联合常规西药治疗对代谢综合征(metabolic syndrome, MS)患者糖脂代谢及肠道菌群-免疫反应的影响。方法 选取 2019年 1月—2020年 8月上海交通大学医学院附属同仁医院收治的54例湿热中阻兼气虚型的MS患者作为研究对象,按照随机数字表法分为对照组(常规西药治疗)与治疗组(常规西药+参连联合治疗),每组各27例。观察2组治疗前后的血糖、血脂、CRP、IL-6、IL-10水平;采用荧光定量PCR法测定肠道细菌DNA,定量分析肠道主要菌群结构变化。结果 与治疗前相比,2组治疗后肠杆菌含量及空腹血糖、TC、TG、LDL-C、CRP、IL-6水平均下降,乳酸杆菌含量、双歧杆菌含量、HDL-C、IL-10水平均升高,其中2组TG、IL-6水平下降及IL-10水平上升差异均有统计学意义,治疗组乳酸杆菌含量升高差异有统计学意义(P均<0.05);治疗组IL-10上升幅度及IL-6下降幅度均大于对照组(P均<0.05)。结论 参连联合常规西药治疗MS患者可提高其外周血免疫炎性因子IL-10水平,降低IL-6水平,明显升高肠道乳酸杆菌含量,对于探索参连联合常规西医治疗的MS患者“肠道菌群-免疫反应”机制研究具有重要意义。
英文摘要:
      Objective To observe the effect of conventional Western medicine with Shenlian combination on glucose and lipid metabolism and intestinal flora-immune response in patients with metabolic syndrome (MS). Methods Fifty-four MS patients with syndrome of damp-heat blocking middle jiao and qi deficiency collected from Tongren Hospital, Shanghai Jiao Tong University School of Medicine from January 2019 to August 2020 were included in this study, and they were randomly divided into control group (conventional Western medicine) and treatment group (Shenlian combination + conventional Western medicine), with 27 cases in each group. The levels of blood glucose, blood lipid, CRP, IL-6, IL-10 in 2 groups were observed before and after treatment. The intestinal bacterial DNA and the structural changes of main intestinal flora were quantitatively analyzed by fluorescence quantitative PCR. Results Compared with before treatment, content of colibacillus, the levels of fasting blood glucose, TC, TG, LDL-C, CRP and IL-6 decreased, but Lactobacilli, Bifidobacterial, the levels of HDL-C and IL-10 increased after treatment in 2 groups. Among them, the decrease of TG, IL-6 and the increase of IL-10 in 2 groups were statistically significant. The increase of Lactobacilli in the treatment group was statistically significant (P<0.05). Compared with the control group, the IL-10 increase and IL-6 decrease in the treatment group were greater (P<0.05). Conclusions The combined treatment of conventional Western medicine and Shenlian combination can increase the level of immune inflammatory factor IL-10 in peripheral blood, reduce the levels of IL-6, and obviously elevate the content of Lactobacillus in intestinal tract in MS patients. Our finding is of great significance on the investigations regarding Shenlian combination with conventional Western medicine on intestinal flora-immune response in MS patients.
HTML   查看全文   下载PDF阅读器
关闭